Roquette, a provider of pharmaceutical excipients and plant-based ingredients, announced a strategic investment with Beren Therapeutics P.B.C., and the launch of an innovation agreement to expand the full potential of Beren’s cyclodextrin technologies and their medicinal applications. Beren is a vertically integrated biopharmaceutical company focused on addressing the world’s most significant health challenges. Roquette recognizes the revolutionary potential of Beren’s research to transform t...